cholestyramine resin has been researched along with oligonucleotides in 1 studies
Studies (cholestyramine resin) | Trials (cholestyramine resin) | Recent Studies (post-2010) (cholestyramine resin) | Studies (oligonucleotides) | Trials (oligonucleotides) | Recent Studies (post-2010) (oligonucleotides) |
---|---|---|---|---|---|
2,669 | 342 | 190 | 23,128 | 245 | 7,331 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, T; Can, A; Castro, VM; Dligach, D; Du, R; Finan, S; Gainer, V; Murphy, S; Savova, G; Shadick, NA; Weiss, ST; Yu, S | 1 |
1 other study(ies) available for cholestyramine resin and oligonucleotides
Article | Year |
---|---|
Lipid-Lowering Agents and High HDL (High-Density Lipoprotein) Are Inversely Associated With Intracranial Aneurysm Rupture.
Topics: Adult; Aged; Aneurysm, Ruptured; Benzimidazoles; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Ezetimibe; Female; Fibric Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Intracranial Aneurysm; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Oligonucleotides; PCSK9 Inhibitors; Propensity Score; Protective Factors | 2018 |